PLOS Medicine publishes research and commentary of general interest with clear implications for patient care, public policy or clinical research agendas.
Policy Forum articles provide a platform for health policy makers from around the world to discuss the challenges and opportunities in improving health care to their constituencies.
* E-mail: firstname.lastname@example.org
Centre for Paediatrics, Blizard Institute, Queen Mary University of London, London, United Kingdom,
MRC Clinical Trials Unit, London, United Kingdom,
Zvitambo Project, Harare, Zimbabwe
MRC Clinical Trials Unit, London, United Kingdom
Children's Infectious Disease Clinical Research Unit, Faculty of Health Sciences, Stellenbosch University and Tygerberg Children's Hospital, Tygerberg, South Africa
Mulago Hospital, Paediatric Infectious Diseases Clinic, Kampala, Uganda
University Teaching Hospital, Lusaka, Zambia
ICAP, Mailman School of Public Health and College of Physicians & Surgeons, Columbia University, New York, New York, United States of America
We want your feedback. Do these subject areas make sense for this article? If not, click the flag
next to the incorrect subject area and we will review it. Thanks for your help!
Also considere the "genetic barrier" to resistance Posted by Blanche
Ambra 2.10.17 Managed Colocation provided by Internet Systems Consortium.
Send us feedback
Help using this site